Clinical implications of hepatitis B virus envelope protein variation

Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC, Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325, 1990 Carman WF, McIntyre G, Klein H, Mutation of HBsAg in homograft recipients receiving hyperimmune globulin. J Hepatol 16: S9, 1992 Carman WF, Thomas H, Domingo E, Viral genetic variation: hepatitis B virus as a clinical example. Lancet 341: 349, 1993 Carman WF, Wallace L, Korula J, MacPhee R, Decker R, Natural occurrence of arginine at aa 145 of HBsAg undetected by current assays, causing fulminant hepatitis (abstract). Abstracts of the 1993 International Symposium on Viral Hepatitis and Liver Disease. Tokyo, 10–14 May, p 289, 1993 Carman WF, Wallace L, Ward K, Hawkins A, Rice S, Tedder R, Variable HBsAg reactivity over time (1986 and 1989); association with mutations (abstract). Abstracts of the 1993 International Symposium on Viral Hepatitis and Liver Disease. Tokyo, 10–14 May, p 129, 1993 Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, Sakaki Y, Okochi K, Nakajima E, Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 184: 115, 1992 Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ, Independent emergence of a vaccine-induced escape mutant of hepatitis-B virus. J Hepatol 13: S105, 1991 Harrison TJ, Hopes EA, Yi Z Keow LG, Oon CJ, Zuckerman AJ, Mutations in hepatitis B virus (HBV) in carriers with co-existent surface antigen and antibody (abstract). Abstracts of the 1993 International Symposium on Viral Hepatitis and Liver Disease. Tokyo, 10–14 May, p 124, 1993 Hino K, Okuda M, Hashimoto O, Ishiko H, Okita K, A vaccine-induced escape mutant of hepatitis B virus (HBV) in a family clustered with HBV infection (abstract). Abstracts of the 1993 International Symposium on Viral Hepatitis and Liver Disease, Tokyo 10–14 May, p 124, 1993 Howard CR, Brown SE, Hogben DN, Zuckerman AJ, Murray-Lyon IM, Steward MW, Analysis of antibody responses to hepatitis B surface antigen. In: Vyas GN, Dienstag JL, Hoofnagle JH (eds) Viral hepatitis and liver disease. Grune and Stratton, Orlando, Florida, USA, pp 561–572, 1984 Howard CR, Karthigesu V, Allison L, DMello F, Fortuin M, Whittle H, Hepatitis B virus variants with altered a determinants causing infections in immunised children (abstract). Abstracts of the 1993 International Symposium on Viral Hepatitis and Liver Disease. Tokyo, 10–14 May, p 75, 1993 Imai M, Gotoh A, Nishioka K, Kurashina S, Miyakawa Y, Mayumi M, Antigencity of reduced and alkylated Australia antigen J Immunol 112:416, 1974 Itoh Y, Takai E, Ohnuma H, Kitayima K, Tsuda F, Machida A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M, A synthetic peptide vaccine involving the product of the pre-S2 region of hepatitis B virus: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 83: 9174, 1986 Le Bouvier GL, The heterogeneity of Australia antigen. J Infect Dis 123: 671, 1971 Machida A, et al, A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumens. Gastroenterology 86:910, 1984. McMahon G, Ehrlich, PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, Östberg L, Genetic alterations in the gene encoding, the major HBsAg: DNA and immunological analysis of recurrent HBsAg, derived from monoclonal antibody-treated liver transplant patients. Hepatology 15: 757, 1992 Meyer zum Büschenfelde K-H, Gerken G, Hess G, Manns M, The significance of the pre-S region of the hepatitis B virus. J Hepatol 3: 273, 1986 Milich DR, McNamara MK, McLachlan A, Thornton GB, Chisari FV, Distinct H-2 linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. Proc Natl Acad Sci USA 82: 8168, 1985 Milich DR, McLachlan A, Chisari FV, Kent SBH, Thornton GB, Immune response to the pre-S1 region of the hepatitis B surface antigen [HBsAg]: a pre-S1 region of the hepatitis B bypass nonresponsiveness to the pre-S2 and S regions of HB-sAg. J Immunol 137:315, 1986. Moriyama K, Nakajima E, Hohjoh H, Asayama R, Okochi K, Immunoselected hepatitis B virus mutant. Lancet 337: 125, 1991 Neurath AR, Kent SBH, Strick N, Taylor P, Stevens CE, Hepatitis B virus contains pre-S gene-encoded domains. Nature 315:154, 1985 Norder H, Couroucé A-M, Magnius LO, Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 73: 3141, 1992 Ogata N, Zanetti AR, Miller RW, Purcell RH, Biological characterisation in chimpanzees of a possible neutralisation escape mutant of hepatitis B virus with a mutation in the surface gene (abstract). Abstracts of the 1993 Intrnational Symposium on Viral Hepatitis and Liver Disease, Tokyo, 10–14 May p. 124, 1993 Okamoto H, Yano K, Nozaki Y, et al, Mutations within, the s gene of hepatitis-B virus transmitted from mothers to babies immunized with hepatitis-B immune globulin and vaccine. Pediatr Res 32: 264, 1992 Persing DH, Varmus HE, Ganem D,Inhibition of secretion of hepatitis B surface antigen by a related presuface polypeptide. Science 234: 138, 1986 Santantonio T, Jung MC Schneider R, et al. Hepatitis-B virus geonomes that cannot synthesise pre-S2 proteins occur frequently-and as dominant virus populations in chronic, carriers in Italy. Virology 188: 948 1992 Szmunes W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A, Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N Engl J Med 303: 833, 1980 Thoma HA, Hemmerling AE, Firusian N, Koller E, Kapfer G, Does the pre-S2 have the same effect in improving the HBV immune response compared to pre-S1? In: Hollinger FB, Lemon SM, Margolis HS (eds) Viral hepatitis and liver disease. Williams and Wilkins, Baltimore, pp 736–742, 1990 Tiollais P, Pourcel C, Dejean A, The hepatitis B virus. Nature 317:489, 1985 Tran A, Kremsdorf D, Capel F, Houffet C, Dauguet C, Petit MA, Brechot C, Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection. J Virol 65: 3566, 1991 Waters J, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC, Loss of the common a determinant of hepatitis B surface antigen by a vaccine induced escape mutant. J Clin Invest 90: 2543, 1992